InsiderClue
Insiders · Profile

MCANDREW STEPHEN J

SVP Bus. Strat. & Dev. at Outlook Therapeutics. Filing since 11 Nov 2016. CIK 0001227041

Company
Date
Role
Action
Shares
Amount
Of holding
OTLK Outlook Therapeutics, Inc.
22 Dec 2017
SVP Bus. Strat. & Dev.
Bought
15,705
$17.75K
44.6%
OTLK Outlook Therapeutics, Inc.
11 Nov 2016
SVP Bus. Strat. & Dev.
Sold, plan not stated
21,367
$80.13K
36.9%
2 decisions on file.